JFL Life Sciences Stock Screener | Share Price & Fundamental Analysis
JFLLIFE
Pharmaceuticals
Screen JFL Life Sciences share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹39.76 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.99
EPS (TTM)
₹1.26
Dividend Yield
-
Debt to Equity
0.22
52W High
-
52W Low
-
Operating Margin
11.00%
Profit Margin
5.33%
Revenue (TTM)
₹75.00
EBITDA
₹8.00
Net Income
₹4.00
Total Assets
₹72.00
Total Equity
₹40.00
JFL Life Sciences Share Price History - Stock Screener Chart
Screen JFLLIFE historical share price movements with interactive charts. Analyze price trends and patterns.
JFL Life Sciences Company Profile - Fundamental Screener
Screen JFL Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JFLLIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0LA901015
JFL Life Sciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen JFLLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 72 | 57 | 49 | 48 | 29 | 24 | 16 |
| Current Assets | 60 | 44 | 41 | 39 | 21 | 18 | 14 |
| Fixed Assets | 12 | 13 | 7 | 7 | 7 | 5 | 3 |
| Liabilities | |||||||
| Total Liabilities | 72 | 57 | 49 | 48 | 29 | 24 | 16 |
| Current Liabilities | 1 | 1 | 2 | 9 | 8 | 1 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 40 | 36 | 32 | 11 | 7 | 5 | 5 |
| Share Capital | 33 | 11 | 11 | 8 | 1 | 0 | 0 |
| Reserves & Surplus | 7 | 25 | 21 | 3 | 6 | 5 | 5 |
Screen JFLLIFE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 75 | 82 | 47 | 45 | 35 | 33 | 30 | 32 |
| Expenses | 67 | 74 | 42 | 39 | 28 | 31 | 28 | 31 |
| EBITDA | 8 | 8 | 5 | 6 | 6 | 2 | 2 | 1 |
| Operating Profit % | 11.00% | 10.00% | 10.00% | 9.00% | 16.00% | 7.00% | 6.00% | 4.00% |
| Depreciation | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 6 | 4 | 4 | 4 | 1 | 1 | 0 |
| Tax | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 4 | 4 | 3 | 3 | 3 | 1 | 0 | 0 |
| EPS | 1.10 | 1.26 | 1.00 | 2.90 | 4.12 | 0.89 | 0.66 | 0.59 |
JFL Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen JFLLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -4 | 8 | -9 | 2 | -6 | 3 | -3 |
| Investing Activities | 0 | -6 | 1 | -1 | -2 | -3 | -1 |
| Financing Activities | 4 | -2 | 8 | -2 | 7 | 0 | 4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen JFLLIFE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Apr |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 92.52% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.77% | 28.95% | 28.88% | 28.06% | 28.37% | 28.48% | 28.80% | 0.00% |
| Other Holding | 3.76% | 3.58% | 3.66% | 4.47% | 4.16% | 4.06% | 3.73% | 7.48% |
| Shareholder Count | 997 | 1,022 | 998 | 825 | 966 | 873 | 832 | 21 |
JFL Life Sciences Dividend Screener - Share Yield Analysis
Screen JFLLIFE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
JFL Life Sciences Index Membership - Market Screener Classification
Screen JFLLIFE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
JFL Life Sciences Market Events Screener - Corporate Actions
Screen JFLLIFE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.25 /share | 4.68% | ||
| Annual General Meeting | NA | 9.54% | ||
| Bonus | 2:1 | 1.06% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -2.17% |
| 2025-10-28 | 2025-10-28 | Extraordinary General Meeting | NA | 1.16% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 1.42% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 20.85% |
| 2025-04-08 | 2025-04-08 | Quarterly Result Announcement | NA | 4.52% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 26.39% |
JFL Life Sciences Competitors Screener - Peer Comparison
Screen JFLLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
JFL Life Sciences Company Announcements - News Screener
Screen JFLLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.